HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ariel F Grajales-Cruz Selected Research

B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)

1/2020Assessment of the Efficacy of Therapies Following Venetoclax Discontinuation in CLL Reveals BTK Inhibition as an Effective Strategy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ariel F Grajales-Cruz Research Topics

Disease

1Cytopenia
12/2022
1Multiple Myeloma
12/2022
1Infections
12/2022
1B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2020

Drug/Important Bio-Agent (IBA)

1idecabtagene vicleucelIBA
12/2022
1venetoclaxIBA
01/2020

Therapy/Procedure

2Therapeutics
12/2022 - 01/2020